Financial Data and Key Metrics Changes - In Q4 2025, net sales were $891 million, with adjusted EBIT of $122 million and a margin of 13.7% [4][13] - For the full year 2025, net sales reached $3.58 billion, with adjusted EBIT of $510 million and a margin of 14.2% [4][5] - Adjusted free cash flow for the year was $403 million, demonstrating disciplined execution [4][17] Business Line Data and Key Metrics Changes - The company secured new light vehicle turbo awards, increasing share in gasoline VNT applications and hybrid platforms [6][8] - Diesel applications for light commercial vehicles and trucks remained resilient, contributing to over 23% of sales [8] - The company experienced growth in commercial vehicle sales, particularly in off-highway applications [15][72] Market Data and Key Metrics Changes - Gasoline volumes declined outside of Europe, particularly in Asia, while commercial vehicle and diesel sales grew [15] - The company recovered $10 million and $40 million of tariffs in Q4 and for the full year, respectively [15][16] Company Strategy and Development Direction - The company aims to strengthen its core business while accelerating zero-emission technologies [5][12] - A strategic collaboration with Trane Technologies was announced to integrate next-generation oil-free compressors into commercial HVAC applications [9][22] - The company targets to achieve over 5% of revenue from industrial cooling by the end of the decade [11][22] Management's Comments on Operating Environment and Future Outlook - Management anticipates further share of demand gains, margin expansion, and strong free cash flow for 2026 [5][20] - The company expects a 2% decline in the global light vehicle industry but projects growth in its own market share [20][70] - The outlook for 2026 includes net sales of $3.7 billion and adjusted EBIT of $545 million, implying a 14.7% margin [20][21] Other Important Information - The company repaid $50 million of its term loan and repurchased $208 million of common stock in 2025 [5][18] - A $250 million share repurchase program was authorized for 2026, with a target distribution of approximately 75% of adjusted free cash flow to shareholders [18][19] Q&A Session Summary Question: Economic opportunity from the Trane partnership - Management indicated that the first application will be delivered in 2026, with a significant ramp-up expected in 2027, but specific numbers for 2027 were not provided [26][28] - The partnership is expected to contribute to the 5% revenue target by the end of the decade, with CapEx included in the 2.5% guidance for 2026 [28][29] Question: Comparison of power generation and cooling opportunities - Management noted that both markets are growing rapidly, with significant demand for energy and cooling solutions [40][44] - The cooling segment is forecasted to exceed 5% of revenue, with a quick ramp-up expected [45] Question: New light vehicle turbo awards and market share - Management confirmed a consistent win rate above 60% in the turbocharger market, indicating an increase in market share [46][49] - The company is well-positioned to capture demand driven by technology advancements in hybrid vehicles [49][50] Question: Efficiency gains from the Trane e-compressor - Management highlighted that their solution offers controllability and maintenance advantages over competing technologies [52][54] - The company is focused on continuous efficiency improvements across its operations [55] Question: Trane partnership exclusivity and addressable market - Management confirmed that while the partnership with Trane is significant, there will be opportunities to work with other players in the future [59][62] - The $1 billion revenue target for zero-emission products remains a priority, with multiple drivers contributing to this goal [78]

Company Overview - Oculis is a Swiss-based biopharma company focused on improving eye care and saving patients' vision, with operations in the US and Iceland [2] - The company has developed a differentiated pipeline of drug candidates for conditions such as diabetic macular edema (DME) and acute optic neuritis (AON) [2] Pipeline and Drug Candidates - Oculis has several late-stage clinical studies, including OCS-01, a potential treatment for DME, which affects over 37 million people globally, projected to rise to 53 million by 2040 [1][2] - OCS-01 is the first topical eye drop for DME, with two fully enrolled Phase 3 trials (DIAMOND) involving over 800 patients, and topline data expected in 2Q26 [7][10] - The company plans to submit a New Drug Application (NDA) to the FDA in 2H26, with the DME market estimated at $5 billion globally [7][10] - Oculis is also developing privosegtor (OCS-05) for AON and NAION, with several clinical trials underway, including positive results from Phase 2 trials [8][11] Financial Position - As of the end of Q3, Oculis had $182.2 million in cash and liquid assets, which increased to $300 million following a capital raise campaign in October [9] Analyst Insights - Analysts view Oculis as offering a diversified ophthalmology pipeline with high unmet needs, particularly for DME with OCS-01 showing promising efficacy and safety [10] - The stock has received a Strong Buy consensus rating, with a price target of $38 indicating an 81% upside potential, while the current stock price is $20.97 [11]

Summary of the Conference Call Company Overview - **Company**: BorgWarner - **Industry**: Automotive and Powertrain Supply Key Points and Arguments Supply Chain Disruptions - BorgWarner faced supply disruptions impacting sales, including: - A cyber attack affecting JLR, resulting in a $35 million sales impact in Q3 [3] - Ford's aluminum supplier issue expected to impact BorgWarner by $50-$100 million in Q4 [3][4] - Semiconductor challenges with Nexperia have shown signs of improvement [3] Growth Dynamics - The company has experienced a backlog shift due to changes in the EV market, tariffs, and reshoring [5] - BorgWarner's outgrowth has been around 1% for 2024 and 2025, primarily due to unmaterialized volumes from won programs [6] - The company announced 17 new programs in the last six months, indicating a high level of activity [6] - Under new CEO Joe's leadership, there is a cultural shift encouraging all business units to seek growth opportunities [7] Foundational vs. E-Product Business - The foundational business is expected to see organic growth declines, but there are opportunities in turbochargers and all-wheel drive systems [11][12] - Advanced hybrid vehicles present significant content opportunities, with potential revenue four to five times that of pure combustion engines [15] - The e-products segment, particularly PowerDrive, has shown strong growth, especially in Europe and Asia [19][22] Margin Resilience - Despite organic growth declines, BorgWarner has maintained strong margins through cost controls, restructuring savings, and supply chain efficiencies [28][30] - The company aims for mid-teens earnings per share growth, leveraging cost management strategies [32] Automation and AI - BorgWarner has implemented AI in manufacturing for cost benefits, particularly in visual inspections and R&D processes [34][35] Battery Business Outlook - The battery segment has faced challenges but remains EBITDA positive and free cash flow positive, with a focus on long-term growth [26][41] Free Cash Flow and Capital Allocation - The company expects to generate approximately $900 million in free cash flow, a 20% increase year-over-year [59] - CapEx is currently low at 4% of revenue, but historically it has been around 5-6% [61] - BorgWarner is balancing share buybacks and M&A opportunities, with a focus on accretive investments [66] Regional Dynamics and China Exposure - Approximately 20% of BorgWarner's revenue comes from China, with 75% of that from local OEMs [48] - The company maintains a disciplined approach to ROIC in China, focusing on profitability despite competitive pressures [49][54] - There are opportunities for Chinese OEMs to expand into Europe, which could benefit BorgWarner [56] Conclusion - BorgWarner is navigating supply chain challenges while focusing on growth in both foundational and e-product segments. The company is committed to maintaining strong margins and free cash flow, with strategic investments in automation and a disciplined approach to capital allocation. The outlook for the battery business remains cautiously optimistic, and the company is well-positioned to capitalize on opportunities in the evolving automotive landscape.

Company Overview - BorgWarner is recognized as a global leader in both legacy combustion technologies, such as turbochargers, and in eProducts [1] - The company is actively involved in vehicle technology and mobility sectors [1] Leadership and Strategy - Joe Fadool, who became CEO earlier this year, has outlined key priorities for the company [2] - The leadership team, including the CFO Craig Aaron and Pat Nolan from Investor Relations, is engaged in discussions to address these priorities [2]

Group 1 - Battery Electric Vehicles (BEVs) are disrupting Garrett Motion's (NASDAQ: GTX) legacy product portfolio of turbochargers, but this disruption is not indicative of a decline in the company's prospects [1] - The transition from Internal Combustion Engine (ICE) vehicles to BEVs presents both challenges and opportunities for Garrett Motion [1] Group 2 - The article emphasizes the importance of understanding the evolving automotive landscape and its impact on traditional automotive suppliers like Garrett Motion [1]